338601
A framework for improving aid effectiveness in global health in the 2030 agenda
These are some of the questions that will be answered in this presentation. With tangible examples and practical tools, the presenter will turn the admirable and impotance practice of charity, foreign aid and global health assistance upside down to demonstrate innovative ways to get a bigger ROI and achieve sustainable results. The presentation will have three parts. First, the presenter will use a human rights approach and international law to describe the main reasons for improving aid effectiveness in global health. Second, the presenter will list the main barriers to delivering effective aid and how to detect them, and third, the presenter will describe the steps the audience needs to put into practice to improve the effectiveness and sustainability of the 2030 global health agenda. Finally, the presenter will give the audience actionable recommendations to achieve the third sustainable development goal (SDG3), that is, delivering aid that effectively helps ensure healthy lives and promotes well-being for all at all ages.
Learning Areas:
Public health administration or related administrationSystems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Describe the importance of improving aid effectiveness in global health in the 2030 global health agenda
List the steps to assess the degree of effectiveness of a donor-funded project of initiative
List the steps to improve the effectiveness of global health interventions
Keyword(s): Health Systems Transformation, Public Health Administration
Qualified on the content I am responsible for because: I have over 25 years of international health experience
Any relevant financial relationships? Yes
Name of Organization | Clinical/Research Area | Type of relationship |
---|---|---|
Realizing Global Health | President | Employment (includes retainer) |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.